Dolutegravir + lamivudine (Dovato)

Status:
Red
Decision Date:
September 2019
 

Comments

RED: Treatment of HIV-1 infection in adults and adolescents aged>12 years weighing ≥40kg, with no known or suspected resistance to the integrase inhibitor class, or lamivudine.

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app